物联网生态环境 > 可穿戴设备博客



Samsung, Omron & Profusa Aim to Make Harvesting Medical-Grade Data Effortless

by Steven Waltzer | 2月 02, 2016

Medical grade wearables are currently held back by a host of factors ranging from bio-sensor cost and accuracy, to a stuck-in-its-ways medical establishment, to an onerous (and arguably rigid) FDA approval process. Wearables for healthcare, however, represent a potentially huge portion of the longer term wearables market.  Medical data will become a vital output stream coming from everyday wearables that are stylish, affordable, and indispensable.

The medical wearables market is without doubt in its infancy and the first wave of devices are certainly big, bulky and in need of refinement both in terms of industrial design and the user experience. However, we expect to see rapid evolution of the category as numerous enabling technology vendors get to work moving the products down the cost, size, and power curve. We expect to see a tsunami of medical wearable devices in 2016 and beyond. MWC in Barcelona this month will see a wide range of vendors building on the CES 2016 launches. At CES 2016, we highlighted the Omron Project Zero blood pressure watch, the Samsung bio-processor, and the Profusa Lumee injectable as category moving catalysts. At MWC, we expect to see a wide array of both enabling technologies and solutions.

Strategy Analytics will have a strong presence at MWC 2016 with numerous analysts attending from various practice areas.  To arrange a meeting with us at MWC please click here.

Previous Post: AR Smartglasses Leader VUZIX & Partners Deliver an HVAC Field Service Solution to Drive New Levels of Customer Satisfaction | Next Post: Biosensor Penetration Outlook: Not All Biometrics are Created Equal in the Eyes of Regulatory Agencies
Leave a comment